Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227836 · ClinicalTrials.gov registry record · NA
Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02227836: Completed NA study, sponsored by Mayo Clinic.
NCT02227836 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02227836, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study is being done to see if allergy patch testing (APT) can help predict effective dietary therapy in patients with eosinophilic esophagitis.
Primary Outcome
Sensitivity of the patch test will be defined by the number of subjects with total positive APT reactions correlated to histologic findings
Interventions
- DEVICE Allergy Patch Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-09 |
| Phase | NA |
What the finished NCT02227836 record still lists
NCT02227836 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Allergy Patch Testing is the first listed.
NCT02227836 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02227836 about?
NCT02227836 is a clinical study titled "Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis". This study is being done to see if allergy patch testing (APT) can help predict effective dietary therapy in patients with eosinophilic esophagitis.
What is the current status of trial NCT02227836?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2014-08. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02227836?
The interventions under investigation include: Allergy Patch Testing (DEVICE).
Who is sponsoring clinical trial NCT02227836?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02227836's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia